J&J to acquire Firefly Bio for $1 billion
In an effort to increase the number of oncology medications in its portfolio, Johnson & Johnson (J&J) said on Monday...
John Reed
In an effort to increase the number of oncology medications in its portfolio, Johnson & Johnson (J&J) said on Monday...
